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Summary 
During T  cell development, interaction of the T  cell receptor (TCR) with cognate ligands in 
the thymus may result in either maturation (positive  selection) or death (negative selection). 
The intracellular pathways that control these opposed outcomes are not well characterized. We 
have generated mice expressing dominant-negative P.as (dnRas) and Mek-1 (dMek) transgenes 
simultaneously, either in otherwise normal animals, or in animals expressing a transgenic TCR, 
thereby permitting a comprehensive analysis of peptide-specific selection. In this system, thy- 
mocyte maturation beyond the CD4+8 + stage is blocked almost completely, whereas negative 
selection, assessed using an in vitro deletion protocol, is quantitatively intact. This suggests that 
activation of the mitogen-activated protein kinase (MAPK) cascade is necessary for positive se- 
lection, but irrelevant for negative selection. Generation of~/~ and of CD4-8-  tx/13 T  cells 
proceeds normally despite blockade of the MAPK cascade.  Hence, only cells that mature via 
conventional, TCP.-mediated repertoire selection require activation of the MAPK pathway to 
complete their maturation. 
E 
xpansion of immature progenitor cells intrathymically 
gives rise to three distinct types ofT lymphocytes: con- 
ventional CD4-  or CD8-bearing T  cells that utilize ot/13- 
type TCR.s, ot[3 cells lacking CD4 and CD8 (and generally 
expressing the NK1.1  marker), and T  cells expressing the 
~//8  TCR..  In  each  cell  lineage,  development  proceeds 
through a series of defined stages to ensure that each lym- 
phocyte  expresses  a  functional TCR.  In  the  most  thor- 
oughly  studied  case,  CD4+8 +  (double-positive)  thymo- 
cytes that express ctl3 TCILs interact with stromal cells that 
display class I and II products of the MHC. Most double- 
positive thymocytes bear TCP..s that do not recognize the 
MHC molecules present in the thymus, and these cells die 
relatively rapidly through a process  termed "death by ne- 
glect" (1). In contrast, recognition of self-MHC antigen- 
presenting structures, presumably beating bound peptide, 
can trigger either functional differentiation (positive  selec- 
tion) or apoptosis (negative selection). 
This paradoxical feature of T  cell development, that a 
single receptor can deliver signals to induce either matura- 
tion or death, is central to the process  of thymocyte devel- 
opment,  but  remains  poorly  understood.  A  favored hy- 
pothesis  (the  avidity  model)  postulates  that  positively 
selecting peptide/MHC complexes interact with the TCIL 
with low affinity, or are present in low numbers, and de- 
liver a weak signal that rescues  cells from their default fate 
(death by neglect) without inducing apoptosis.  In contrast, 
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an  especially  avid  interaction  between  individual  TCR- 
bearing  thymocytes and  antigen-presenting  stromal  cells 
could provide a strong signal, thereby provoking deletion (2). 
Experiments in which peptide antigens are added at in- 
creasing concentrations to cultured fetal thymuses provide 
some support for this model in that antigen dose was found 
to regulate the yield of mature-appearing CD4-8 + cells 
(3,  4).  However it is not clear that cells  derived via this 
protocol have truly acquired mature, functional characteris- 
tics. Other experiments (5) suggest that agonist peptides in- 
variably provoke negative selection, whereas true positive 
selection, that yielding functional cells, is only achieved us- 
ing nonstimulatory peptide ligands (those with antagonist 
properties) in thymic organ culture (5, 6).  These observa- 
tions argue that the TCR-coupled signaling mechanism in 
developing thymocytes responds in a qualitatively different 
way to distinct peptide/MHC complexes: it can sense the 
character of an agonist peptide, even when it is present in 
very low  abundance,  and  thereafter deliver an  apoptotic 
signal. 
If the  responses  to  positively and  negatively selecting 
peptides differ qualitatively, then the T cell signaling mech- 
anisms stimulated by these two classes ofligands should also 
be distinguishable. Some information regarding the impor- 
tance of different TCR-coupled signaling molecules in se- 
lection has emerged through study of animals bearing tar- 
geted  mutations  in  the  genes  that  encode  them.  For 
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precursors proceed unimpaired infyn null animals (7,  8). In 
contrast, thymocytes lacking the zeta-associated protein 70 
(ZAP-70)* kinase cannot sustain either positive or negative 
selection (9).  Hence, the differential recruitment  of signal- 
ing complexes that permits a distinction between positively 
and negatively selecting ligands must occur at a point distal 
(in biochemical  terms)  to  ZAP-70 in the  signal transduc- 
tion cascade. 
In previous  studies,  we  demonstrated  that inhibition  of 
signaling  through  p21 r~  or the  mitogen-activated  protein 
kinase  (MAPK)  Mekl  (achieved  in  both  cases  by  thy- 
mocyte-specific  expression  of a  dominant-negative  trans- 
gene) caused a marked reduction in the  efficiency of posi- 
tive  selection  without  affecting negative  selection  (8,  10). 
These  observations  suggested  that  the  mitogen-activated 
protein kinase (MAPK) pathway might be involved specifi- 
cally in positive selection. 
Although expression of high levels of dominant-negative 
Ras (dnRas) or Mek-1  (dMek) proteins in thymocytes sub- 
stantially  blocks  thymocyte  maturation,  this  inhibition 
rarely exceeds 70%. Moreover, the inhibition of MAPK ac- 
tivation,  while proportional to the  amount of dMek trans- 
gene  expressed  in  the  thymocytes,  was  never  complete. 
Hence, it remained possible that quantitative  differences in 
the strength of TCR-derived signals could explain the rela- 
tively  discrete  interdiction  of positive  selection  in  these 
transgenic mice. If, using the same signal transduction com- 
ponents,  negatively  selecting  stimuli  deliver  substantially 
stronger signals than  do positively selecting stimuli,  partial 
inhibition  of the MAPK cascade might attenuate  only the 
outcomes  from  the  weakest  signaling  events.  This  argu- 
ment  predicts  that  complete  inhibition  of Ras  signaling 
would affect both positive and negative selection, just as is 
seen with targeted disruption of the Zap-70 gene. 
To address this possibility, we have imposed a more pro- 
found block in the  MAPK cascade by simultaneously  ex- 
pressing both dnRas and dMek-1,  and have examined the 
efficiency  of negative  selection  in  such  cells  using  an  in 
vitro  deletion  system where  the strength  of the signal can 
be controlled experimentally. We have also studied the de- 
velopment of~/8 and NKl.l+oq3 T  cells in these mice. Our 
results  demonstrate  that stimulation  of the MAPK cascade 
is absolutely required for the satisfactory selection of mature 
TCR-c~/[3-bearing  single-positive  ceils,  but  is  apparently 
irrelevant  for other  thymocyte lineages.  Moreover,  nega- 
tive  selection  proceeds  unimpaired,  and  with  identical 
dose-response  characteristics,  in  the  absence  of effective 
Ras  pathway  signaling.  These  results  indicate  that  TCRs 
can  deliver  very  different  types  of signals  by variably  re- 
cruiting distinct, downstream signal transduction pathways. 
~  Abbreviations used in this paper: dMek, dominant-negative Mek-1; dnRas, 
dominant-negative Ras; HSA, heat-stable antigen; MAP, mitogen-acti- 
rated protein; MAPK, mitogen-activated protein kinase; ZAP-70, zeta- 
associated protein 70. 
Materials and Methods 
Transgenic Mice.  The  generation  of dnRas  (lines 15465  and 
15728),  dMek  (fine A1665),  OT-I  and  H-Y  TCR  transgenic 
mice has been previously described  (5, 8, 10, 11), 
Peptides.  Peptides were synthesized  at  the Biopolymer Syn- 
thesis Facility, Department of Immunology (University of Wash- 
ington)  using an Applied Biosystems  (Foster  City,  CA)  instru- 
ment. 
How Cytometric Analysis.  Thymocytes were stained  with sat- 
urating concentrations of antibody at 4~  for 30 min. Cells were 
examined for surface expression  of the following molecules: CD4 
(PE  L3T4),  CD8  (FITC Ly-2; Caltag Laboratories,  South  San 
Francisco,  CA); CD3~  (FITC- PE-  or biotin-conjugated,  145- 
2C11), HSA (biotinylatedJ1 ld), 0L[3  TCR (biotinylated H57-597), 
"y8 TCR (PE-CGL3), V"/3 (FITC-563), and CD69 (biotinylated 
H1.2FC; PharMingen, San Diego, CA). The H-Y TCR c~ chain 
was  stained  with  biotinylated T3.70  (11),  and the  OVA-TCR 
with the Vel2-specific  antibody B20.1  (12). Biotinylated antibod- 
ies were visualized  using trichrome-labeled streptavidin  (Caltag). 
Analyses were performed using a FACScan  |  flow cytometer with 
Lysis II software  (Becton Dickinson & Co., San Jose, CA). Subse- 
quent  data  analysis used  ReproMan  software  (True  Facts  Soft- 
ware,  Seattle,  WA).  Cell sorting was performed on a dual  laser 
FACStar Plus  |  instrument (Becton Dickinson & Co.). 
Western Blotting.  Thymocytes were lysed  on ice for 15  min 
with lysis buffer (10 mM Tris-HC1, pH 7.6,  150 mM NaC1,  1% 
NP-40, 5 mM EDTA, 50 mM NaF, 0.4 mM Na3VO4, 10 mM 
iodoacetamide, 5 mM sodium pyrophosphate, 1 mM PMSF, and 
1 mg/ml aprotinin, leupeptin, pepstatin  A, and chymostatin) and 
then centrifuged for 5 rain at  15,000 g.  The protein concentra- 
tion in the supernatants  was determined by the Bradford method. 
The lysates were fractionated by 10% SDS-PAGE gels under re- 
ducing  conditions  and  then  electrotransferred  to  nitrocellulose 
paper.  The nitrocellulose  filters were blocked for 45 rain at 37~ 
in PBS, pH 7.2, 0.1% Tween-20, and 5% milk powder, and then 
incubated with primary antibody (ras 10, Ab-3 from Oncogene 
Sciences, Uniondale, NY; and anti-Mek mAb from Transduction 
Laboratories,  Lexington, KY)  for 1 h. After three 5-rain washes 
with PBS/01% Tween-20, the blots were incubated with horse- 
radish peroxidase-conjugated sheep anti-mouse antiserum for 30 
min,  washed extensively,  and developed by enhanced chemilu- 
minescence (Amersham Corp., Arlington Heights, IL), according 
to the manufacturer's instructions. 
Suspension Deletion Assay.  EL4 cells were irradiated  and plated 
at 5  X  104/well  in round bottom sterile 96-well plates. The dif- 
ferent peptides,  OVAp  (SIINFEKL), E1  (EIINFEKL), V-OVA 
(RGYNYEKL), and p-SER (SSYSYSSL) were diluted in RPMI 
at  different  concentrations  and  added  to  the  plates.  Total  thy- 
mocytes lffom OT-I, OT-I/dnKas, OT-I/dMek, and OT-I/dnRas/ 
dMek were then added to the plates at 5 X 10S/well and incubated 
for 18 h  at  37~  An aliquot of the  thymocytes was  stained  at 
time 0. At the end of the culture, the cells were stained with bi- 
otinylated CD69, anti-CD4-PE, anti-CD8-FITC, and streptavi- 
din-Tricolor. The number of viable double positive  cells was de- 
termined by means  of a live gate and a tight DP gate.  EL4 cells 
were excluded from the analysis based on forward and right-angle 
light scattering.  Induction of CD69 was determined by recording 
the mean fluorescence intensity of FL3 on total  double positive 
thymocytes. 
PCR.  Genomic DNA was prepared as described by Laird et al. 
(13), and PCR amplification  reactions  were performed in 50 p~l 
reaction buffer (50 mM KCI, 20 mM Tris-HC1,  pH8.3, 2.5 mM 
MgC12, and 0.1 mg/ml BSA) containing 0.5 p~g template DNA, 
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and 1 U  AmpliTaq DNA polymerase (Perkin-Elmer Cetus, Fos- 
ter City, CA). The amplification cycle (1  rain at 95~  2 rain at 
60~  and 5 min at 72~  was repeated 25 times. The 5' primers 
were specific for H-1Kas (5'-CCAAGTCCTTTGAAGACATC- 
CATCAG-3') and Mek-1  (5'-CCCGGGGGATCCCTTGCT- 
CATACGGA-3') and the 3' for the hHGH sequence present in 
the transgene (5'- TGGCAACTTCCAAGGCCAGGAGAG-3'). 
Results 
The combination of dnRAS and dMek Completely Abrogates 
Generation of Single-positive ~8 T  Cells.  To  generate  mice 
in  which  activation of the  1Kas signaling pathway in thy- 
mocytes  was  severely impaired,  we  crossed  animals  from 
the transgenic lines 15465  (dnlKas) and A1665  (dMek) and 
examined the development of T  cells in their progeny (see 
Materials and Methods). Doubly transgenic thymocytes ex- 
pressed the same amounts  of each transgene-encoded pro- 
tein  as  did cells from  the parental lines  (data not  shown). 
Although  the  thymuses  of the  doubly  transgenic  animals 
were normal in size and cellularity, phenotypic analysis of 
the thymocytes revealed a dramatic decrease in the genera- 
tion  of single-positive, TC1K  hi  cells.  Fig.  1  demonstrates 
that the proportion of single-positive thymocytes, reduced 
to  "-'40%  of normal  in  the  singly transgenic animals, was 
further reduced in the doubly transgenic mice to <10% of 
control  values.  Typically,  the  number  of  CD4+8 -  or 
CD4-8 +  cells was  reduced  to  <1%  of total  thymocytes, 
and the proportion of CD3 hi cells, normally ~--15%, was re- 
duced to ~1%, most of which represented products of dif- 
ferent  lineages  (Fig.  1  and  see  below).  Hence,  the  two 
transgenes, acting in concert, produce a much more com- 
plete blockade of thymocyte development than does either 
alone. 
It is worth  noting that  the yield of mature  cells in  the 
doubly transgenic mice corresponds to what would be ex- 
pected if the inhibitory effects of one  transgene were  im- 
posed on those cells that escape the influence of the other. 
For example, the yield of mature  cells relative to those in 
normal animals is ~0.4 in mice expressing dnRas or dMek, 
and (0.4  X  0.4)  =  0.016 in the case where both transgenes 
were present. This result is consistent with biochemical and 
genetic data derived from other systems that position Mek-1 
downstream ofp2V  ~ in a linear signaling cascade (14-16). 
Distinguishing Positive and Negative Selection in the H-YTCR 
System.  Since the appearance of single-positive cells is al- 
most  completely blocked in  mice  expressing both  dnlkas 
and dMek transgenes, we tested to see whether TC1K sig- 




NLC  dMek 
I  9.3  :  1.5  "~ 
%:.-...  ~  ;~."  "..  ￿9  ￿9  '4"  "  ~  .  ,.  ~'.  ~,./-  ", ..;;...:  ￿9 
~~176  ~4K~:'5'  -  .L,~i 
.,:'.:."  e~.'"  ...-.~-,,::  ",.::,"  ..... 
~o J  ~.'::"". ~  . .:.i!~r.-.,  ... 
0.3  .,.  : 
dnRas  dMek/dnRas 
1.5  "  [  0.2  -.. 
. 
,  ....-.~  ~  r.~  y...'.y  ~  :..'q  F.:7 
::i:  03  i:717 
.....  'i'6 .....  Z6"o  ......  i'k  .....  i'oK :"  ~ ......  1'6  ......  f6"o  .......  fk  ......  f '& 
CD8 
A 
4.5  ~  1.1 
F---------q 
,  ,,,...  ,  ..,..,,  .  ,m,  ..,  ,  ,,,.  .......................  . ........ 
~oo  ~K  ~oK  ~o  '  '~;k 
CD3 
Figure 1.  dnRas and dMek act in concert to inhibit the generation of CD3  ~ single-positive  thymocytes.  Thymocytes from 6-wk old mice derived from 
the cross of dnRas (line 15465) ￿  dMek (line A1665) transgenic animals  were stained with anti-CD4-PE, anti-CD8-FITC, biotinylated anti-CD3e, and 
streptavidin-Tricolor, and analyzed by flow cytometry as described in Materials and Methods. The presence of the transgenes was determined by PCR 
and Western blotting. Shown are histograms for a normal littermate control (NLC), single transgenic animals expressing dnRas or dMek, and a double 
transgenic animal (dMek/dnRas). (Top) Two-color, CD4 vs CD8, histogram. The percentage of single-positive thymocytes in the boxed areas is indi- 
cated. (Bottom)  Representation of CD3 ha cells in the thymuses of the different animals. The experiment shown is representative of more than five litters 
examined. 
11  Alberola-Ila  et al. rupted.  This was achieved by simultaneously introducing a 
third transgene, H-Yc~[3, encoding a TCR  of known spec- 
ificity that recognizes a male-specific antigen in the context 
of H-2D  b.  Previous  studies  document  the  utility  of this 
model system for the analysis of both positive and negative 
selection  events.  In  adult  male  animals,  virtually  all  thy- 
mocytes are deleted  during development through interac- 
tion of the H-Y-specific TCR with cognate ligand, whereas 
in female mice, selection of CD4-8 + class I-restricted thy- 
mocytes proceeds efficiently (11,  17). Triply transgenic mice 
were  obtained  by  crossing  mice  heterozygous  for  dMek 
(line A1665) to mice bearing a dnRas transgene (line  15728) 
and the transgene encoding the H-Y TCR  (previously bred 
onto a C57BL/6 background). Progeny of these crosses were 
genotyped by PCR, and the animals were analyzed by three- 
color flow cytometry at 4-6 wk of age. 
As we have previously shown, the presence of either dn- 
Ras  or  dMek  dramatically  decreases  the  generation  of 
CD4-8 +  thymocytes  in  transgenic  H-Y~xl3  female  mice. 
This effect is best visualized by gating on cells undergoing 
positive selection that express high levels of the transgene- 
encoded TCR  c~ chain (18), where a 95% reduction in the 
proportion  of CD4-8 +  ceils  is  typically  observed.  Coex- 
pression of both dnRas and dMek had very little  effect on 
the already very low levels of mature cells generated in the 
thymus (Fig.  2).  However the increased inhibition  of thy- 
mocyte  development  could be  appreciated  in  the  spleen, 
where  the  number  of CD8 +  T  cells  was  significantly re- 
duced (from 30% of normal in doubly transgenic animals to 
~5-10%  of normal in the triply transgenic  mice).  Despite 
this dramatic reduction in the generation of CD8 + T  cells, 
negative selection in male mice bearing the H-Y~xl3  trans- 
gene  remained  intact  (Fig.  3).  These  results  reinforce  the 
view that  the  Ras/Raf/Mek/MAP  kinase  pathway is dis- 
proportionately required for effective positive selection. 
Quantitative Analysis of Negative Selection Using an OVA- 
specific TCR.  Despite  the  seemingly  normal  propagation 
of negatively selecting signals in the H-Yal3/dnRas/dMek 
C~ 
U 
HY  HY / dnRas  HY / dMek / dnRas 
.  .;.;'~;"~..~]L".&-  i 
~-.'..'.~~'.'."  ....  ,  .'11.2 
~og 
~  8 
36~  2~ 
l  ....... 
~o  1oo  ix 
5.0 
￿9  @ 
fox  1o  ~oo 
7 
227  ~'i 




,,  ..,,, 




N-  SPL  .;:v-:::.~...,..  ""'~ .....  "  ~'  '  "  / 
￿9  "I~'~'..C~ ......  :~'k;  u;  ....  ￿9  ~.!  :'~:..~  ,~.  ,;." 
Q')  ~0  " '  "~'?":""  '~"  ~  tjt'"  .':"  """  "  "~ "  }i:'~'Kr  ~;:"::i~  N~..  '"  "  ~i:  "  .....  ￿9  ~:---7  ?.2"  "'~"  ";" "" 
~i:':,  1.8  ~.:.  0.5  '-h  0.2  / 
~~,~~f~:J':'  ,~:'::"  ~i~;.'-s 
1  io  1oo  ix  1ox  1o  1oo  IK  fox  ~.o  too  i:4  fox 
CD8 
Figure  2.  Effect  of  dnRas 
and/or  dMek on positive selec- 
tion  of  thymocytes bearing 
H-Y~x~ TCR. Thymocytes and 
splenocytes from  6-wk-old  lit- 
termate female progeny of H-Y/ 
dMek (A1665) X dnRas (15728) 
or H-Y/dnRas (15728) X dMek 
(A1665)  crosses  were  stained 
with  anti-CD4-PE,  anti-CD8- 
FITC, biotinylated T3-70  (anti- 
H-Y TCR c~ chain) and strepta- 
vidin-Tricolor, and analyzed by 
flow cytometry. Shown are two- 
parameter  histograms of  CD4 
and  CD8  expression  in  thy- 
mocytes (THY) and spleenocytes 
(SPL) for the  thymocytes, total 
cells in a live gate (U) are com- 
pared with those cells present in a 
T3-70  hi  (H-Y  TCR  o  0,  small 
forward scatter gate (G)  as de- 
scribed (10). The numbers indi- 
cate the  percentage of cells in 
each region in the ungated (U) 
histograms, or the total number 
of cells from  100,000 (thymus) 
total events in  the  gated panel 
(G). The  combination of both 
dMek and dnRas further inhibits 
the  generation of CD8 +,  H-Y 
TCR  + cells. This is best appreci- 
ated in  the  spleen. Shown is  a 
representative experiment out of 
three. 
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Figure 3.  Negative selection of H-Y TCR-bearing thymocytes is not 
affected by dnR.as and dMek. Thymocytes from 6-wk-old littermate male 
progeny  of  H-Y/dMek  (A1665)  ￿  dnRas  (15728)  or  H-Y/dnR.as 
(15728)  ￿  dMek (A1665)  crosses were stained with anti-CD4-PE, anti- 
CD8-FITC, biotinylated T3-70 (anti-H-Y TCR ~x chain), and streptavi- 
din-Tricolor, and analyzed  by flow cytometry.  The phenotype of the an- 
imals was determined by Western blotting and/or PCR as described in 
Materials and Methods. Shown are two-parameter histograms of CD4 
and CD8 expression in thymocytes. The number of thymocytes  present 
in the male animals was similar (1.2-1.6 X 107 cells). Shown is a represen- 
tative litter out of three examined. 
triply transgenic mice, it remained possible that some sig- 
nificant inhibition of these signals  was in fact taking place, 
but that the overall strength of the negative selection signals 
was too great to permit appreciable reduction in the elimi- 
nation  of cells  by Ras  pathway  blockade.  To  gain  addi- 
tional  insight  into  the  nature  of negative  selection,  we 
made use of a second TCR transgene (OT-I), derived from 
an H-2Kb-restricted T  cell clone reactive with an octamer 
peptide  (SIINFEKL, termed OVAp)  representing residues 
257-264 of ovalbumin. This system is especially useful be- 
cause the negative selection phenomenon can be modeled 
directly in  thymocytes using an in  vitro peptide  addition 
system (19).  The OVAp peptide will induce T  cell activa- 
tion  and  in  vitro  thymocyte  deletion  at  concentrations 
where  only 80  peptide/MHC  complexes are  formed per 
presenting cell (20).  In addition, variant peptides have been 
characterized that require somewhat higher (El) or dramat- 
ically higher (V-OVA) concentrations ofpeptide to induce 
negative selection (Hogquist, K.A., unpublished results). 
Thymic development in OVA (bearing the OT-I trans- 
gene), OVA/dnRas, OVA/dMek and OVA/dnRas/dMek 
animals  was  analyzed by three-color flow cytometry in 
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4-wk-old animals. As in other systems, the presence of ei- 
ther the  dnRas  or the  dMek transgene  resuked in  a  60% 
decrease in the generation of CD4-8 + thymocytes, and the 
combination of both transgenes was again much more effi- 
cient,  decreasing  the  numbers  of mature  CD8 +  cells  by 
>90%.  Gating on cells  expressing high levels of the OT-I 
o~ chain provided a  direct  demonstration of the profound 
inhibition of positive selection, with <2% the normal num- 
ber of CD8-bearing cells represented (Fig.  4). 
An interesting feature of OT-I transgenic animals is the 
presence  in  their  thymuses  of a  CD4+CD8 ~~ population 
which may represent thymocytes that have inappropriately 
downregulated  the  correct  coreceptor  (21).  Alternatively, 
these cells may represent normal intermediates in the com- 
mitment pathway for CD4-8 + cells  (22,  23). Regardless of 
their precise provenance, the generation of this population 
is also  dramatically inhibited  in the presence  of dnRas  or 
dMek,  and  most  profoundly  when  both  transgenes  are 
present,  indicating that this  early step in the commitment 
process leading to the generation of single-positive cells re- 
quires  activation of the  MAPK cascade  (Fig.  4).  It is  also 
notable  that,  as in  the  H-Yot[3  transgenic  animals  (8,  10, 
and Fig.  1),  there is a population  of transgenic  TCR  cx  hi, 
double-negative cells,  products  of a distinct  differentiative 
pathway (24) whose generation is not affected by the pres- 
ence ofdnRas, dMek, or both. 
Since  the  combination  of dnRas  and  dMek  efficiently 
blocks positive selection signals generated after ligand occu- 
pancy of the OT-I receptor, we tested for impairment of de- 
leting  signals  derived  from  the  same  receptor  complex. 
This was done by incubating total thymocytes for 18 h  in 
the presence of  increasing concentrations of test peptides, and 
thereafter analyzing the  representation  of viable CD4+8 + 
cells.  Inhibition  of negative  selection  should  appear  as  a 
shifting of the  dose-response  curve to  the  left,  such  that 
substantially  higher  concentrations  of test peptide  are  re- 
quired to produce an equivalent degree of cell death. Fig. 5 
demonstrates that this is not the case. When the maximally 
stimulatory OVA-p peptide agonist was used,  efficient de- 
letion occurred with a K ael (half-maximal deletion) value of 
10 -12  M,  regardless  of whether  thymocytes  bearing  the 
OT-I transgene alone, or the OT-I transgene with dnRas, 
dMek, or both, were examined. Hence effective inhibition 
of the  R.as/R.af/Mek/MAP  kinase  cascade  did  not  affect 
the fidelity of signaling leading to in vitro deletion when a 
strong agonist was used. Remarkably, much the same result 
was  obtained  when  weaker agonist peptides  were  tested. 
Thus for E1  (K  del  =  10 -8 M), no significant differences in 
the dose of peptide required for deletion were seen in the 
doubly or triply transgenic mice (Fig. 5). Hence, if negative 
and  positive  selection  differ  only  with  respect  to  the 
strength of activation of otherwise identical signaling path- 
ways, the magnitude of the difference in strength must be 
extremely large, sufficient to permit complete blockade of 
positive selection while leaving intact weak negatively se- 
lecting signals,  which  by titration  differ by four orders  of 
magnitude from optimally deleting stimuli.  Differences of 
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Figure 4.  Inhibition  of positive selection ofthymocytes bearing the OT-I TCR by dnRas, dMek, or both. Thymocytes from 4-wk-otd F  1 progeny of 
homozygous  OT-1 X dnRas/dMek crosses were stained with anti-CD4-PE, anti-CD8-FITC, biotinylated  B20.1  (anti-Vc~2 specific, to identify  cells 
bearing the OVA-specific  transgenic TCR), and streptavidin-Tricolor,  and analyzed by flow cytometry.  The phenotype of the animals was determined 
by Western  blotting and/or PCR. Shown are two-parameter histograms of CD4 and CD8 expression from cells in a live gate (U) and cells present in a 
B20.1 hi (OVA-I TCR or), small forward scatter gate (G). The numbers indicate the percentage of cells in each region in the ungated (U) histograms, and 
total number of cells from 100,000 total events in the gated panels (G). The combination of dMek and dnRas inhibits the generation  of CD8 §  B20.1 + 
cells most efficiently. Note also that the generation  of B20.1 + CD4-CD8- cells is not affected. Shown is a representanve  experiment out of three. 
erned by the affinity of the TCR  for its ligand,  since mea- 
sured variations among partial agonists typically fall within a 
narrow range  (25).  Importantly,  the dnRas  and dMek trans- 
genes  do  not  themselves  promote  thymocyte  killing since 
the  extraordinarily  weak  V-OVA  agonist  (K  d*l  >10 -5  M) 
provoked  equivalent  deletion  in  thymocytes  from  all four 
types oftransgenic mice (Fig. 5). 
Inhibition  of the Ras-MAPK Pathway Does  Not Affect  the 
Development of other T Cell D'neages.  Although doubly trans- 
genic dnRas/dMek  mice have  few thymocytes  expressing 
high levels of the TCR,  some such cells can be detected in 
these  animals,  and  the  numbers  of these  ceils  exceed  the 
combined numbers  ofCD4-8  + and CD4+8 -  ceils (Fig.  1). 
These  observations  prompted  more  detailed  evaluation  of 
minority  lineages  of  thymocytes  in  mice  expressing  the 
dominant-negative transgenes. 
To analyze  the development of 3'8 T  cells, pregnant  fe- 
males  resulting  from  crosses  of dnRas  with  dMek  mice 
were  killed  between  days  E15.5  and  E19.5,  the  fetuses 
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V-OVA (RGYNYEKL)  Figure 5.  Peptide-specific  deletion  of OVA- 
TCR-bearing thymocytes proceeds unimpaired 
1~  in the presence of dnRas,  dMek, or both. Thy- 
mocytes  from  4-wk-old  F  1 progeny  of  ho- 
mozygous  OVA-TCR ￿  dnRas/dMek crosses 
were  incubated  overnight  with  APCs  (EL4) 
"  that had been preloaded with different peptides, 
|]a"]]  and were then stained with anti-CD4-PE, anti- 
/I 
CD8-FITC,  biotinylated  anti-CD69,  and 
streptavidin-Tricotor,  and analyzed by flow cy- 
tometry to determine the number of surviving 
double-positive  cells, as described  in Materials 
,  ,  ￿89  ,  ,  ~  ,  ,  :~  ,  ,  and  Methods.  The  phenotype  of the  animals 
~  ~  ~  ~  was  determined  by  Western  blotting  and/or 
PCR. Shown are the results obtained  after in- 
[PEPTIDE]  cubating  the  OVA-TCR  +  thymocytes  with 
APCs preloaded  with different amounts  of the 
cognate peptide  (OVAp), a partial agonist peptide  (El), and an antagonist peptide  (V-OVA). An unrelated peptide  (poly-Ser) able to bind to K  b did not 
induce deletion  (data not shown). Shown are the results of a representative experiment out of three. 
14  Absolute Requirement for MAP Kinase Activation in Positive Selection genes was confirmed by immunoblot analysis of thymic ly- 
sates￿9 Thymic cellularity was simultaneously assessed by three- 
color flow cytometry. As shown in Fig. 6, ~/B T  cells were 
present  in  normal  numbers  in  animals  expressing  dnlKas, 
dMek, or both. Similar results were obtained when the de- 
velopment  of V73-expressing  thymocytes,  a  population 
that ordinarily appears very early in ontogeny (26), was as- 
sessed.  Appearance  of V73-bearing  cells  requires  signals 
from p56 Ick (27),  but  was  not  at  all  compromised  by the 
presence of the dnlKas or dMek transgenes (Fig. 6). 
To confirm that these  cells were actually expressing the 
inhibitory transgenes  at levels comparable with those seen 
in o~13 thymocytes, we sorted 78 cells  from fetal thymuses 
(E16.5)  and  measured  the  expression  of Mek  protein.  As 
shown in Fig.  7, "18 thymocytes express this protein,  97% 
of which is transgene encoded, at levels 24-fold higher than 
those  seen  in  total  thymocytes from normal  mice.  Since 
this value is in good accord with the known level of trans- 
gene expression in conventional cx~ thymocytes, interdic- 
tion  of the  1Kas/1Kaf/Mek/MAP  kinase  signaling  cascade 
does  not  appear  to  compromise  development  of mature 
78+HSA  -  cells.  Similarly,  NKI.1 +  c~[3 T  cells,  a popula- 
tion ofT cells representing an independent lineage that un- 
dergoes  selection  after  interaction  of the  TC1K  with  the 
CD1 atypical class I molecule (28, 29), develop normally in 
mice bearing the dnlKas and/or dMek transgenes  (data not 
shown).  We  conclude  that  activation  of the  R.as  signal 
transduction pathway is obligatory for maturation  of con- 
ventional  CD4+8 -  and  CD4-8 +  thymocytes bearing  oLI3 
TC1Ks, but plays a less important role, and perhaps no role 
at all,  in directing the maturation  of other T  cell lineages. 
More remarkably, within the conventional o~13 T  cell mat- 
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Figure  6.  ~/8 T cells are generated in normal num- 
bers in the presence of dnRas and/or dMek. Timed 
matings were established by adding one dMek trans- 
genic male to a cage of three dnRas transgenic females 
for 16 h. The day the males were removed was consid- 
ered day 0.5. At different time points, pregnant females 
were killed and the thymocytes from the fetuses stained 
with a V73-specific antibody and J1 ld (HSA specific), 
or with anti-7~ TCR-PE, anti-CD3-FITC,  biotiny- 
lated anti-TCIK [3, and streptavidin-Tricolor, and ana- 
lyzed by flow cytometry. The phenotype of the ani- 
mals was determined by Western blotting. Shown is a 
two-parameter stain for V73 and HSA (top) and a sin- 
gle-parameter histogram of total 7B cells (bottom) in 
16￿9  fetal thymocytes￿9  The numbers represent (top) 
total numbers of cells (out of 100,000 events) and the 
percentage ofTB  + cells (bottom). 
15  Alberola-Ila et al. Figure 7.  ~B cells from E16.5 normal littermate control  and  dMek 
transgenic animals were sorted, washed, counted, and lysed. The lysates, 
including a separate lysate from normal thymocytes, were  analyzed by 
Western blotting. The density of the bands was quantified by densitome- 
try, yielding the indicated values. Since the A1665 line expresses ~30- 
fold excess Mek protein (10), the predicted density value from 1.5  ￿  104 
cells would be 2.3. 
uration  scheme,  activation  of the  MAPK  cascade  permits 
positive selection, but need not occur for satisfactory prop- 
agation of signals leading to negative selection. 
Discussion 
The  interaction  of the  TCR  with  its ligands,  molecules 
of the  MHC  with  bound  peptides,  may  induce  different 
functional  consequences  in T  cells,  ranging from prolifera- 
tion to anergy in mature cells, or from differentiation  (pos- 
itive selection)  to apoptosis  (negative  selection)  during  de- 
velopment  (1).  Although  recent  experiments  using altered 
peptide  ligands  have  shown  the  importance  of the  pre- 
sented  peptide  in  determining  the  cellular  response  (3-5, 
30),  the  mechanisms  employed  by  the  TCR.  to  impose 
these  different  outcomes  are  not  well  understood.  Recent 
results indicate that both positive and negative selection are 
inhibited  in thymocytes from animals lacking  ZAP-70  (9), 
suggesting that, at a proximal point from the TCR,  a single 
mutation  can block all possible outcomes of TCR  engage- 
ment. In contrast,  our results demonstrate that inhibition  of 
the  MAPK  cascade  defines  a  branch  point  in  the  TCR- 
derived signal transduction  cascade. 
Previous genetic and biochemical studies make plain that 
p21 '~ sits at a pivotal control point in a serine/threonine  ki- 
nase  signaling  pathway.  Activation  of Ras  occurs  through 
16 
the  action  of the  guanine  nucleotide  exchange  factor Sos, 
permitting  accumulation  of Ras  in  its  GTP-bound  form. 
This Ras-GTP  complex binds to the Rafkinase and directs 
it  to  the  plasma  membrane  where  it  is activated  (31,  32). 
Raf in  turn  phosphorylates  the  MAP  kinase  Mek-1  (33), 
which thereafter phosphorylates and activates MAP kinases. 
These MAP kinases can phosphorylate transcription  factors 
directly, or can impinge upon still other signaling pathways 
(see reference 15 for a review of this cascade). 
Even  though  expression  of either  dnRas  (8)  or  dMEK 
(10)  specifically  inhibited  positive  selection,  some  single- 
positive cells were still generated in these mice. These cells 
could  represent  a  population  that  does  not  require  Ras- 
derived signals for maturation,  or could result from incom- 
plete attenuation  of the Ras signaling pathway by the dom- 
inant-negative  transgene  products.  Indeed,  biochemical 
analysis showed that the blockade  of MAPK activation,  al- 
though  proportional  to  the  amount  of dominant-negative 
transgene  expressed,  was  never  complete  (10).  Here  we 
have shown  that simultaneous  introduction  of both domi- 
nant-negative  transgenes  blocks  maturation  of single-posi- 
tive thymocytes almost entirely. Since Ras and Mek partic- 
ipate  in  the  same  signaling  pathway  from  the  TCR,  and 
since  the  combined  effects  of the  transgenes  mimic  what 
would  be  expected  from  each  acting  independently,  we 
conclude  that  maturation  of  conventional  CD4+8 -  or 
CD4-8 +  o~13 T  cells from CD4+8 +  progenitors  absolutely 
requires signaling via the Ras-initiated  kinase cascade. 
Although  it  is possible  that  dnRas  and  dMek  block  so- 
called  accessory  signals,  known  to  be  required  for  thy- 
mocyte maturation,  which  are triggered by thymic stromal 
elements,  all evidence  suggests  that  it  is the  TCR-derived 
signal  itself that  undergoes  attenuation.  TCR  stimulation, 
even  in  double-positive  thymocytes,  stimulates  the  MAP 
kinase cascade  (Alberola-Ila, J.,  unpublished  results),  hence 
an accessory signal that acted in this way would provide no 
information beyond what was communicated by the TCR 
itself. More to the point,  dnRas and dMek block upregula- 
tion of CD69  in vivo  (8,  10),  which  is a  TCR-dependent 
event.  Hence  activation of Ras,  almost certainly as a  result 
of a signal transduction  process initiated  at the TCR,  is re- 
quired for maturation of conventional,  0r  T  cells. 
Abrogation  of  ZAP-70  signaling  seemingly  blocks  all 
thymocyte developmental events that require  TCR  stimu- 
lation.  In contrast,  complete interdiction  of the MAPK cas- 
cade does not affect TCR-induced  negative selection at all. 
These results cannot easily be made consonant with models 
that  seek  to  explain  the  distinction  between  positive  and 
negative  selection  based  on  quantitative  variations  in  the 
"strength"  of the signal (presumably reflecting the total flux 
of catalytic  events)  along a  single,  unbranched  pathway.  If 
such were the case, attenuation  of this signaling pathway at 
any point  should  yield results like  those  obtained  in  ZAP- 
70 -/-  mice.  Hence,  with  respect  to  biological  effects,  the 
TCR  signaling pathway must at least bifurcate downstream 
of ZAP-70,  and at least one of the resulting branches  must 
serve  to  stimulate  the  Ras  pathway.  The  existence  of 
branched TCR  signaling pathways makes understandable  a 
Absolute Requirement for MAP Kinase Activation in Positive  Selection process whereby ligand  occupancy of the  receptor might 
provoke different  outcomes:  depending  upon  the  ligand, 
activation  of different  signaling  branches  might be  selec- 
tively favored, whether as a result of kinetic (34,  35) or al- 
losteric (36) considerations. However Ras activation, though 
necessary for positive selection, is almost certainly not suffi- 
cient,  since negatively selecting stimuli also  provoke aug- 
mented  expression  of CD69  (Alberola-Ila, J.,  and  K.A. 
Hogquist, unpublished results),  a Ras-dependent event (37). 
Thus whereas Ras signals  must be present,  additional  sig- 
nals must also be absent if positive selection is to result. 
Together, our studies and those of others suggest a mod- 
ified view of the process whereby the  avidity of peptide/ 
MHC-TCR  interactions  regulates  thymocyte  selection. 
Significant occupancy of the TCR is in all cases required to 
permit stimulation of downstream effector pathways, nota- 
bly the Ras/Raf/Mek/MAPK  cascade.  Howqver, at high 
stimulator concentrations owing either to prolonged occu- 
pancy of individual receptors (the kinetic model) or to con- 
formational changes imposed by agonist ligands  that bind 
with  high  apparent  affinity  (the  allosteric  model),  other 
pathways become activated that lead to cell death.  Interest- 
ingly, our studies suggest that these pathways act indepen- 
dently.  If individual thymocytes responded to the ratio of 
signals  derived  from Ras  and  from other pathways,  pep- 
tide-mediated  apoptosis  should  actually  have  occurred 
more efficiently in thymocytes from dnRas and dMek ani- 
mals. Our experiments argue that in the matter of negative 
selection, the ability of the ligand to activate the Ras/Raf/ 
Mek/MAPK  cascade is  irrelevant.  Viewed from this per- 
spective, negative selection appears to involve a specialized, 
independent signaling pathway that requires ZAP-70 acti- 
vation but for which ZAP-70 cannot serve as the sole con- 
trolling element. 
Some support for this assertion already exists.  For exam- 
ple, expression of dominant-negative versions of the nur77 
orphan steroid receptor in thymocytes suppressed negative 
selection, without affecting positive selection (38).  Further- 
more, a superantigen-stimulated cell death signaling path- 
way associated with phospholipase A 2 activation has been 
reported in at least one set of T  cell clones, and was shown 
to be unaffected by stimulatory peptide/MHC ligands (39). 
A similar pathway may well underlie negative selection. 
Finally, there is every reason to believe that the distinc- 
tion  that we observe between Ras pathway signaling and 
the  activation  of  other  biochemical  responses  in  thy- 
mocytes will be maintained in mature T  lymphocytes. Us- 
ing  alternative  promoter  constructs  that  direct  transgene 
expression primarily to the peripheral T  cell compartment 
(40),  it should be possible to assign  these individual signal- 
ing pathways to the biological processes that they control. 
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